SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-15-000525
Filing Date
2015-05-15
Accepted
2015-05-15 16:45:45
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0315_delmarpharma.htm 10-Q 541566
2 CERTIFICATIONS f10q0315ex31i_delmarpharma.htm EX-31.1 10198
3 CERTIFICATIONS f10q0315ex31ii_delmarpharma.htm EX-31.2 11596
4 CERTIFICATIONS f10q0315ex32i_delmarpharma.htm EX-32.1 3558
5 CERTIFICATIONS f10q0315ex32ii_delmarpharma.htm EX-32.2 3566
6 GRAPHIC image_001.jpg GRAPHIC 33401
7 GRAPHIC image_002.jpg GRAPHIC 73851
  Complete submission text file 0001013762-15-000525.txt   4187954

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE dmpi-20150331.xml EX-101.INS 474113
9 XBRL SCHEMA FILE dmpi-20150331.xsd EX-101.SCH 39038
10 XBRL CALCULATION FILE dmpi-20150331_cal.xml EX-101.CAL 27508
11 XBRL DEFINITION FILE dmpi-20150331_def.xml EX-101.DEF 137524
12 XBRL LABEL FILE dmpi-20150331_lab.xml EX-101.LAB 335282
13 XBRL PRESENTATION FILE dmpi-20150331_pre.xml EX-101.PRE 226701
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54801 | Film No.: 15870355
SIC: 2834 Pharmaceutical Preparations